Trimethylamine N-oxide (TMAO) as a new potential therapeutic target for insulin resistance and cancer
Research Use Limitation Used solely for in vitro experiments Not permitted for clinical trials involving humans Not permitted for human or veterinary administration Not permitted for investigational human use Independently analysed by Liquilabs s.r.o
Extraction of data Data from the trials, including the name of the principal investigator, the year of publication, the sample size, and the research design, were extracted using a pre-made template
Email Support Good Available during business hours
Modern, Safe Facilities: Experience comfort and professionalism in the heart of Tijuana
If nausea is a side effect of GLP-1 medications, consider adjusting your meal timing to smaller, more frequent meals